SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

	June 30, 2020		December 31, 2019
	($ in thousands)
Cash and cash equivalents	$	7,318	$	25,813
Restricted cash and cash equivalents	731,292		742,093
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows	$	738,610	$	767,906

Restrictions on Cash and Cash Equivalents

	June 30, 2020		December 31, 2019
	($ in thousands)
Cash and cash equivalents	$	7,318	$	25,813
Restricted cash and cash equivalents	731,292		742,093
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows	$	738,610	$	767,906

Financing Receivable, Allowance for Credit Loss

The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:

	Six months ended June 30
	2020		2019
	($ in thousands)
Balance at beginning of period	$	15,000	$	9,012
Cumulative effect of adoption of ASU 2016-13 at January 1, 2020	750		—
Charge offs	(15,000)		—
Net increase (decrease) in allowance	250		—
Balance at end of period	$	1,000	$	9,012

Schedule of Interest Income and Interest Expense

For the three and six months ended June 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:

	Three months ended June 30				Six months ended June 30
	2020		2019		2020		2019
	($ in thousands)				($ in thousands)
Deposit interest income	$	645	$	1,697	$	1,252	$	2,745
Deposit interest expense	$	—	$	(705)	$	—	$	(753)
Deposit interest income/(expense), net	$	645	$	992	$	1,252	$	1,992

Schedule of Weighted Average Number of Shares

The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and six months ended June 30, 2020 and 2019:

	Three months ended June 30		Six months ended June 30
	2020	2019	2020	2019
Weighted average shares outstanding - basic	35,776,736	36,100,665	35,958,965	36,037,177
Effect of dilutive employee and director share-based awards	—	729,298	—	555,141
Weighted average shares outstanding - diluted	35,776,736	36,829,963	35,958,965	36,592,318
Anti-dilutive stock options outstanding	875,627	935,627	875,627	935,627
Participating securities excluded from calculation of loss per share	1,259,173	—	1,259,173	—